Treatment-resistant anxiety disorders: social phobia, generalised anxiety disorder and panic disorder

被引:0
|
作者
de Menezes, Gabriela Bezerra [1 ]
Fontenelle, Leonardo F. [1 ]
Mululo, Sara [1 ]
Versiani, Marclo [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Psiquiatria, Programa Ansiedade & Depressao, Rio De Janeiro, Brazil
关键词
psychopharmacology; panic disorder; generalized anxiety disorder; drug resistance; social phobia;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives: Anxiety disorders are common psychiatric conditions that cause significant disability, poor quality of life and enormous social cost. Although treatments with demonstrable efficacy are available a great number of patients fail to respond or remains with clinically significant residual symptoms after treatment. The objective of this study is to review aspects related to treatment resistance and pharmacological strategies to deal with anxiety disorders resistant to treatment. Method: Narrative review. Results: We discuss conceptual aspects related to treatment resistance or refractoriness, predictors of poor treatment outcome, and finally, some strategies to deal with anxiety disorders (including social anxiety disorder generalized anxiety disorder and panic disorder) that do not respond to standard therapeutic interventions. Conclusion: Treatment resistance in anxiety disorders remains a challenge to clinical practice going from non standardized concepts of response and resistance to a paucity of controlled studies concerning therapeutic strategies.
引用
收藏
页码:S55 / S60
页数:6
相关论文
共 50 条
  • [1] Treatment-resistant panic anxiety disorder
    Bandelow, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S207 - S208
  • [2] Treatment-resistant social anxiety disorder
    Stein, D. J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S208 - S209
  • [3] PSYCHOPHARMACOLOGICAL TREATMENT OF PANIC, GENERALIZED ANXIETY DISORDER, AND SOCIAL PHOBIA
    ROYBYRNE, P
    WINGERSON, D
    COWLEY, D
    DAGER, S
    [J]. PSYCHIATRIC CLINICS OF NORTH AMERICA, 1993, 16 (04) : 719 - 735
  • [4] Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder
    Massion, AO
    Dyck, IR
    Shea, T
    Phillips, KA
    Warshaw, MG
    Keller, MB
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (05) : 434 - 440
  • [5] Commentary on RANZCP clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder
    Brakoulias, Vlasios
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 (01): : 81 - 82
  • [6] Processing bias in children with separation anxiety disorder, social phobia and generalised anxiety disorder
    Kindt, M
    Bögels, S
    Morren, M
    [J]. BEHAVIOUR CHANGE, 2003, 20 (03) : 143 - 150
  • [7] COMPARISON OF ANXIETY SENSITIVITY IN PANIC DISORDER AND SOCIAL PHOBIA
    HAZEN, AL
    WALKER, JR
    STEIN, MB
    [J]. ANXIETY, 1994, 1 (06): : 298 - 301
  • [8] Plasma neuropeptide Y in anxiety disorders: Findings in panic disorder and social phobia
    Stein, MB
    Hauger, RL
    Dhalla, KS
    Chartier, MJ
    Asmundson, GJG
    [J]. PSYCHIATRY RESEARCH, 1996, 59 (03) : 183 - 188
  • [9] COMPARISON OF SOCIAL ANXIETY IN PATIENTS WITH SOCIAL PHOBIA AND PANIC DISORDER
    MUNJACK, DJ
    BROWN, RA
    MCDOWELL, DE
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1987, 175 (01) : 49 - 51
  • [10] Panic attacks and generalised anxiety disorder
    Van Ameringen, M.
    Mancini, C.
    Simpson, W.
    Patterson, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S534 - S535